cerrar
Tagged with IP

Interview: John Simmons – Vice-President Sales &…
John Simmons, VP Sales & Marketing (Health Systems) at Philips Canada talks about the company’s commitment to delivering integrated health…

Aki Kasvi – General Manager; Mindaugas Plieskis – Head of…
Aki Kasvi and Mindaugas Plieskis of Janssen Baltics discuss their strategic priorities, acting as a strategic partner within the region, and ensuring…

Interview: Maciej Wieczorek – President, Celon Pharma,…
Maciej Wieczorek, president of Celon Pharma, discusses the award-winning success of the 2016 IPO on the Warsaw stock exchange and the opportunities…

Umang Vohra – Global CEO & Managing Director, Cipla
Umang Vohra, managing director and global CEO of Indian pharma giant Cipla, discusses the company’s ambition to grow in both the domestic and…

Interview: Tarik Henein – President, Generic Medical…
Tarik Henein, president of Generic Medical Partners, explains the company’s commitment to improving the lives of Canadians by connecting global…

Interview: Goran M. Orlic – General Manager, INNventa…
Founder and general director of INNventa, Goran Orlic, discusses the rationale behind establishing his own company that continues to double revenues…

Interview: Jeff Dufour – Country Manager; BU Lead Internal…
Jeff Dufour, country manager Switzerland and BU lead Internal Medicine at Pfizer, discusses his first impressions of the country, his priorities for…

Marc Funk – COO, Lonza Pharma & Biotech
Marc Funk, COO of Swiss-headquartered product development service specialist, Lonza, discusses the company’s remarkable recent fortunes, how it is…

Interview: Dilip G Shah – Secretary General, Indian…
Dilip G Shah, secretary-general of the Indian Pharmaceutical Alliance (IPA) and member of the Expert Review Committee on Access to Medicine (ATM),…

Interview: Paul-Émile Cloutier – President, HealthCareCAN,…
Paul-Émile Cloutier, president & CEO of HealthCareCAN, the national voice of healthcare organizations and hospitals across Canada, highlights his…

Jean-Paul Clozel – CEO, Idorsia (October 2017)
In an exclusive interview, Jean-Paul Clozel, former head of Actelion and now CEO of exciting biotech newcomer Idorsia, discusses his new company’s…

Interview: Walid Chriaa – CEO, Society of Pharmaceutical…
Walid Chriaa, CEO of SIPHAT, explains the history of the public company’s position in Tunisia, as the pearl of the Tunisian pharmaceutical industry.…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here